Mycophenolate in treatment‐resistant inflammatory neuropathies
- 1 November 2002
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 9 (6), 683-685
- https://doi.org/10.1046/j.1468-1331.2002.00478.x
Abstract
There has been an increasing interest in the use of mycophenolate as an immunomodulatory drug in neuromuscular diseases. We report five consecutive patients with treatment‐resistant chronic inflammat...Keywords
This publication has 9 references indexed in Scilit:
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnnals of Neurology, 2001
- Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositisJournal of the Neurological Sciences, 2001
- Mycophenolate mofetil for myasthenia gravis: An open-label pilot studyNeurology, 2001
- Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseasesNeurology, 2001
- Treatment of myasthenia gravis with mycophenolate mofetil: A case reportMuscle & Nerve, 2000
- Mycophenolate mofetil and its mechanisms of actionImmunopharmacology, 2000
- Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetilNeurology, 1998
- Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathyJournal of Neuroimmunology, 1997
- Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 1989